AMT — Allegra Orthopaedics Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapSucker Stock
- AU$5.75m
- AU$8.03m
- AU$2.93m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.42 | ||
| Price to Tang. Book | 7.3 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.05 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -100.7% | ||
| Return on Equity | -90.7% | ||
| Operating Margin | -67.49% | ||
Financial Summary
| Year End 30th Jun | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 4.69 | 4 | 5.02 | 4.5 | 2.93 | n/a | n/a | -9.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Allegra Orthopaedics Limited is an Australia-based company engaged in the design and distribution of orthopedic products. It is focused on developing and commercializing medical devices to generate a pipeline of new products at various stages of development. It operates in two segments: Orthopaedics division, and Innovation division. The Orthopaedics division offers a range of orthopedic implant products and surgical instrumentation from Australian and international suppliers covering all specialties from foot and ankle, primary hip and knee, to complex lower limb revision, arthroplasty and tumor solutions. The Innovation division is focused on commercialization of a cervical spinal fusion cage developed from the biocompatible ceramic material, Sr-HT-Gahnite. The Sr-HT-Gahnite is a porous and biocompatible calcium silicate. The applications for the Sr-HT-Gahnite include fixation screws that secure ligaments to the bone, a coating material along with a coating manufacturing process.
Directors
- Peter Kazacos CHM
- Jenny Swain CEO
- Robert Truscott CFO
- Robyn Slaughter SEC
- Nicholas Hartnell NED
- Sean Mulhearn NID
- Last Annual
- June 30th, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- September 1st, 1994
- Public Since
- December 5th, 2007
- No. of Shareholders
- 539
- No. of Employees
- 4,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 104,459,203
- Address
- Se 80 L 8, Lane Cove 18-20 Orion Rd, SYDNEY, 2066
- Web
- http://www.allegraorthopaedics.com/
- Phone
- +61 291199200
- Auditors
- Crowe Horwath Sydney
Upcoming Events for AMT
Similar to AMT
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Analytica
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
What is the Allegra Orthopaedics share price?
As of Today at 18:00 UTC, shares in Allegra Orthopaedics are trading at AU$0.06. This share price information is delayed by 15 minutes.
How has the Allegra Orthopaedics share price performed this year?
Shares in Allegra Orthopaedics last closed at AU$0.06 and the price had moved by -67.65% over the past 365 days. In terms of relative price strength the Allegra Orthopaedics share price has underperformed the ASX All Ordinaries Index by -65.29% over the past year.
What are the analyst and broker recommendations for Allegra Orthopaedics?
There is no consensus recommendation for this security.
What is the Allegra Orthopaedics dividend yield?
Allegra Orthopaedics does not currently pay a dividend.
Does Allegra Orthopaedics pay a dividend?
Allegra Orthopaedics does not currently pay a dividend.
When does Allegra Orthopaedics next pay dividends?
Allegra Orthopaedics does not currently pay a dividend.
How do I buy Allegra Orthopaedics shares?
To buy shares in Allegra Orthopaedics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Allegra Orthopaedics?
As of the previous close price of AU$0.06, shares in Allegra Orthopaedics had a market capitalisation of AU$5.75m.
Where are Allegra Orthopaedics shares listed?
Here are the trading details for Allegra Orthopaedics:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: AMT
What kind of share is Allegra Orthopaedics?
Based on an overall assessment of its quality, value and momentum Allegra Orthopaedics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Allegra Orthopaedics share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the Allegra Orthopaedics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Allegra Orthopaedics. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -47.11%.
As of the last closing price of AU$0.06, shares in Allegra Orthopaedics were trading -75.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Allegra Orthopaedics PE Ratio?
The Allegra Orthopaedics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Allegra Orthopaedics?
Allegra Orthopaedics' management team is headed by:
- Peter Kazacos - CHM
- Jenny Swain - CEO
- Robert Truscott - CFO
- Robyn Slaughter - SEC
- Nicholas Hartnell - NED
- Sean Mulhearn - NID